CARLSMED, INC. (CARL) FY2025 10-K Annual Report
CARLSMED, INC. (CARL) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 25, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
CARLSMED, INC. FY2025 10-K Analysis
Business Overview
- • Core business: proprietary aprevo platform for personalized spine fusion surgical implants using AI-driven surgical planning software
- • New: 2025 launch of FDA-cleared aprevo cervical spine fusion technology and personalized cervical plating solutions
- • Strategic shift: July 2025 IPO converted all preferred stock to common, enhanced equity capital structure and reclassified warrants to equity
- • Quantitative: cash and short-term investments grew to $109.9M in 2025 from $40.2M in 2024, revenue increased $50.5M (+86%)
- • Noteworthy: executed a 1-for-5.58 reverse stock split in July 2025 concurrent with IPO and significant equity recapitalization
Management Discussion & Analysis
- • No revenue, segment, or profitability details disclosed in this MD&A excerpt
- • Risks highlighted on liquidity due to loan covenants and uninsured cash deposits exposure
- • No dividends planned; future returns depend solely on stock price appreciation
- • Potential dilution from future equity issuances per 2025 Equity Incentive and Employee Stock Purchase Plans
- • Forward risks: regulatory compliance costs, internal control requirements, stock price volatility, and acquisition integration uncertainties
CARLSMED, INC. FY2025 Key Financial MetricsXBRL
Revenue
$51M
▲ +85.9% YoY
Net Income
-$30M
▼ -22.2% YoY
Gross Margin
75.3%
▲ +151bp YoY
Operating Margin
-60.5%
▲ +2827bp YoY
Net Margin
-58.7%
▲ +3063bp YoY
ROE
-30.0%
▼ -6432bp YoY
Total Assets
$130M
▲ +151.1% YoY
EPS (Diluted)
$-2.12
▲ +65.3% YoY
Operating Cash Flow
-$29M
▼ -13.8% YoY
Source: XBRL data from CARLSMED, INC. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on CARLSMED, INC.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.